Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ernest

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Annual Review of Pharmacology and Toxicology|August 19, 2020
Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant TuberculosisJacqueline P Ernest, Natasha Strydom, Qianwen Wang, et al.
Journal of Conservative Dentistry : JCD|February 24, 2021
Influence of desensitizing agents in management of noncarious cervical lesion and bonded restorations: A preliminary 12-week reportJ Joyson Joe Asir, I Anand Sherwood, Bennett T Amaechi, et al.
Revue Medicale De Liege|January 25, 2008
[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents]A J Scheen, R P Radermecker, J C Philips, et al.
International Journal of Antimicrobial Agents|June 20, 2022
Pharmacometrics in tuberculosis: progress and opportunitiesJustin J Wilkins, Elin M Svensson, Jacqueline P Ernest, et al.
Arthroplasty Today|April 26, 2019
Rate of surface contamination in the operating suite during revision total joint arthroplastyMatthew J Dietz, Phillip A Bostian, Emily P Ernest, et al.
Clinical Pharmacology and Therapeutics|April 15, 2020
Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug RepurposingMaria Garcia-Cremades, Belen P Solans, Emma Hughes, et al.
Science Translational Medicine|February 5, 2025
Selection and prioritization of candidate combination regimens for the treatment of tuberculosisNatasha Strydom, Rob C van Wijk, Qianwen Wang, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2021
Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling StudyKendra K Radtke, Jacqueline P Ernest, Nan Zhang, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugsJacqueline P Ernest, Janice Jia Ni Goh, Natasha Strydom, et al.
The European Respiratory Journal|June 15, 2023
Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugsJacqueline P Ernest, Janice Jia Ni Goh, Natasha Strydom, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Annual Review of Pharmacology and Toxicology|August 19, 2020
Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant TuberculosisJacqueline P Ernest, Natasha Strydom, Qianwen Wang, et al.
Journal of Conservative Dentistry : JCD|February 24, 2021
Influence of desensitizing agents in management of noncarious cervical lesion and bonded restorations: A preliminary 12-week reportJ Joyson Joe Asir, I Anand Sherwood, Bennett T Amaechi, et al.
Revue Medicale De Liege|January 25, 2008
[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents]A J Scheen, R P Radermecker, J C Philips, et al.
International Journal of Antimicrobial Agents|June 20, 2022
Pharmacometrics in tuberculosis: progress and opportunitiesJustin J Wilkins, Elin M Svensson, Jacqueline P Ernest, et al.
Arthroplasty Today|April 26, 2019
Rate of surface contamination in the operating suite during revision total joint arthroplastyMatthew J Dietz, Phillip A Bostian, Emily P Ernest, et al.
Clinical Pharmacology and Therapeutics|April 15, 2020
Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug RepurposingMaria Garcia-Cremades, Belen P Solans, Emma Hughes, et al.
Science Translational Medicine|February 5, 2025
Selection and prioritization of candidate combination regimens for the treatment of tuberculosisNatasha Strydom, Rob C van Wijk, Qianwen Wang, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2021
Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling StudyKendra K Radtke, Jacqueline P Ernest, Nan Zhang, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugsJacqueline P Ernest, Janice Jia Ni Goh, Natasha Strydom, et al.
The European Respiratory Journal|June 15, 2023
Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugsJacqueline P Ernest, Janice Jia Ni Goh, Natasha Strydom, et al.
Pageof 3